Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 21.

Lacour, Max; Hiltbrunner, Stefanie; Lee, Seok-Yun; Soltermann, Alex; Rushing, Elisabeth Jane; Soldini, Davide; Weder, Walter; Curioni-Fontecedro, Alessandra (2019). Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence. Clinical Lung Cancer, 20(5):391-396.

Dimitriou, Florentia; Mangana, Joanna; Curioni-Fontecedro, Alessandra; Rechsteiner, Markus; Turko, Patrick; Braun, Ralph P; Dummer, Reinhard; Cheng, Phil F (2019). Melanoma patients with additional primary cancers: a single-center retrospective analysis. OncoTarget, 10(36):3373-3384.

Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; Shih, Jin-Yuan; Liao, Wei-Yu; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; Chih-Hsin Yang, James; Lorence, Robert M; Carrière, Philippe; Cseh, Agnieszka; Chang, Gee-Chen (2018). Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC: Findings From a Global Named Patient Use Program. Journal of Thoracic Oncology, 13(12):1897-1905.

Schwyzer, Moritz; Ferraro, Daniela A; Muehlematter, Urs J; Curioni-Fontecedro, Alessandra; Huellner, Martin W; von Schulthess, Gustav K; Kaufmann, Philipp A; Burger, Irene A; Messerli, Michael (2018). Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results. Lung Cancer, 126:170-173.

Britschgi, Christian; Riesterer, Oliver; Burger, Irene A; Guckenberger, Matthias; Curioni-Fontecedro, Alessandra (2018). Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer. Radiation Oncology, 13(1):102.

Curioni-Fontecedro, Alessandra; Ickenberg, C; Franzen, D; Rogler, Gerhard; Burger, Irene A; van den Broek, M (2017). Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with Nivolumab. Annals of Oncology, 28(8):2040-2041.

Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, Adolfo; Froesch, Patrizia; Reguart, Noemí; Puente, Javier; Coate, Linda; Barlesi, Fabrice; Rauch, Daniel; Thomas, Michael; Camps, Carlos; Gómez-Codina, Jose; Majem, Margarita; Porta, Rut; Shah, Riyaz; Hanrahan, Emer; et al (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respiratory Medicine, 5(5):435-444.

Kiessling, Michael K; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Lang, Silvia; Scharl, Michael; Aguzzi, Adriano; Oldridge, Derek A; Maris, John M; Rogler, Gerhard (2017). Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PLoS ONE, 12(1):e0170851.

Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; Sanchez, Ramón Palmero; Villa Guzmán, José Carlos; Martin, Ricardo Collado; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Láng, István; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; et al (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of Thoracic Oncology, 12(4):752-762.

Kiessling, Michael K; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Lang, Silvia; Scharl, Michael; Aguzzi, Adriano; Oldrige, Derek A; Maris, John M; Rogler, Gerhard (2016). Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PLoS ONE, 11(1):e0147682.

Kiessling, Michael K; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Atrott, Kirstin; Cosin-Roger, Jesus; Lang, Silvia; Scharl, Michael; Rogler, Gerhard (2015). Mutant HRAS as novel target for MEK and mTOR inhibitors. OncoTarget, 6(39):42183-42196.

Gautschi, Oliver; Milia, Julie; Cabarrou, Bastien; Bluthgen, Marie-Virginia; Besse, Benjamin; Smit, Egbert F; Wolf, Juergen; Peters, Solange; Früh, Martin; Koeberle, Dieter; Oulkhouir, Youssouf; Schuler, Martin; Curioni-Fontecedro, Alessandra; Huret, Benjamin; Kerjouan, Mallorie; Michels, Sebastian; Pall, Georg; Rothschild, Sacha; Schmid-Bindert, Gerald; Scheffler, Matthias; Veillon, Rémi; Wannesson, Luciano; Diebold, Joachim; Zalcman, Gérard; Filleron, Thomas; Mazières, Julien (2015). Targeted therapy for patients with BRAF-mutant lung cancer: results from the european EURAF cohort. Journal of Thoracic Oncology, 10(10):1451-1457.

Curioni-Fontecedro, Alessandra; Martin, Vittoria; Vogetseder, Alexander; Knuth, Alexander; Moch, Holger; Soldini, Davide; Tinguely, Marianne (2015). Chromosomal aberrations of cancer-testis antigens in myeloma patients. Hematological oncology, 33(3):159-163.

Soldini, Davide; Georgis, Antoin; Montagna, Chiara; Schüffler, Peter Johannes; Martin, Vittoria; Curioni-Fontecedro, Alessandra; Martinez, Antonio; Tinguely, Marianne (2014). The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. Hematological oncology, 32(3):120-125.

Lenggenhager, Daniela; Curioni-Fontecedro, Alessandra; Storz, Martina; Shakhova, Olga; Sommer, Lukas; Widmer, Daniel S; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; Mihic-Probst, Daniela (2014). An aggressive hypoxia related subpopulation of melanoma cells is TRP-2 Negative. Translational Oncology, 7(2):206-212.

Zimmermann, S; Curioni-Fontecedro, Alessandra; Stahel, R; Peters, S (2013). Lung Cancer. In: Dicato, M A. Side Effects of Medical Cancer Therapy. - Prevention and Treatment. London: Springer-Verlag, 119-138.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Dannenmann, Stefanie R; Matter, C; von Boehmer, Lotta; Atanackovic, Djordje; Knuth, Alexander; van den Broek, Maries (2013). MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients. Leukemia, 27(8):1767-1769.

Brandt, Simone; Montagna, Chiara; Georgis, Antoin; Schüffler, Peter J; Bühler, Marco M; Seifert, Burkhardt; Thiesler, Thore; Curioni-Fontecedro, Alessandra; Hegyi, Ivan; Dehler, Silvia; Martin, Vittoria; Tinguely, Marianne; Soldini, Davide (2013). The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Experimental Hematology & Oncology, 2:27.

Curioni-Fontecedro, Alessandra; Frauenfelder, Thomas; Keller, Dagmar (2012). Diagnostic assessment of a pulmonary coin lesions with the example of a young patient. Praxis, 101(5):289-297.

Curioni-Fontecedro, Alessandra; Nuber, Natko; Mihic-Probst, Daniela; Seifert, Burkhardt; Soldini, Davide; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries; Moch, Holger (2011). Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients. PLoS ONE, 6(6):e21418.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Matter, Claudia; Soldini, Davide; Tiercy, Jean Marie; von Boehmer, Lotta; Moch, Holger; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries (2010). Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(34):15187-15192.

This list was generated on Mon Sep 16 18:15:50 2019 CEST.